140 related articles for article (PubMed ID: 37985171)
1. HLH and TET2 Mutation Presenting after First Cycle of CLL Treatment.
Geiger AJ; Yasar DG; Sitwala KV
Clin Med Res; 2023 Sep; 21(3):155-158. PubMed ID: 37985171
[TBL] [Abstract][Full Text] [Related]
2. A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response.
Zoref-Lorenz A; Yuklea M; Topaz G; Jordan MB; Ellis M
J Gen Intern Med; 2022 May; 37(6):1542-1546. PubMed ID: 35178648
[TBL] [Abstract][Full Text] [Related]
3. Filgrastim-induced hemophagocytic lymphohistiocytosis in a patient with mantle cell lymphoma: A case report.
Higuchi S; Lee S; Fujita K; Hara T; Tsurumi H
J Infect Chemother; 2024 Feb; 30(2):150-153. PubMed ID: 37769993
[TBL] [Abstract][Full Text] [Related]
4. Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
Papageorgiou SG; Tsiodras S; Siakallis G; Bazani E; Spathis A; Poulakou G; Korkolopoulou P; Panayiotides I; Pappa V
Pathol Res Pract; 2016 Dec; 212(12):1194-1198. PubMed ID: 28340951
[TBL] [Abstract][Full Text] [Related]
5. A case of hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia after treatment with fludarabine, cyclophosphamide, and rituximab chemotherapy, with autopsy findings.
Tiong IS; Lau MB; Toumoua S; Chiruka S
Case Rep Hematol; 2012; 2012():326053. PubMed ID: 23533846
[TBL] [Abstract][Full Text] [Related]
6. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
[TBL] [Abstract][Full Text] [Related]
7. Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study.
Ninkovic M; Fiegl M; Mian M; Mondello P; Kocher F; Waldthaler C; Verdorfer I; Steurer M; Gastl G; Pircher A
Anticancer Res; 2015 Sep; 35(9):5129-39. PubMed ID: 26254418
[TBL] [Abstract][Full Text] [Related]
8. Expression of granulocyte colony-stimulating factor and granulocyte colony-stimulating factor receptor genes in partially overlapping monoclonal B-cell populations from chronic lymphocytic leukemia patients.
Corcione A; Corrias MV; Daniele S; Zupo S; Spriano M; Pistoia V
Blood; 1996 Apr; 87(7):2861-9. PubMed ID: 8639905
[TBL] [Abstract][Full Text] [Related]
9. Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis.
Alomari A; Hui P; Xu M
Int J Surg Pathol; 2013 Jun; 21(3):303-8. PubMed ID: 23129836
[TBL] [Abstract][Full Text] [Related]
10. Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.
Lee-Vergés E; Hanna BS; Yazdanparast H; Rodríguez V; Rodríguez ML; Giró A; Vidal-Crespo A; Rosich L; Amador V; Aymerich M; Villamor N; Delgado J; Lichter P; Pérez-Galán P; López-Guerra M; Campo E; Seiffert M; Colomer D
Int J Cancer; 2019 Jun; 144(11):2762-2773. PubMed ID: 30468254
[TBL] [Abstract][Full Text] [Related]
11. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Woyach JA; Ruppert AS; Heerema NA; Zhao W; Booth AM; Ding W; Bartlett NL; Brander DM; Barr PM; Rogers KA; Parikh SA; Coutre S; Hurria A; Brown JR; Lozanski G; Blachly JS; Ozer HG; Major-Elechi B; Fruth B; Nattam S; Larson RA; Erba H; Litzow M; Owen C; Kuzma C; Abramson JS; Little RF; Smith SE; Stone RM; Mandrekar SJ; Byrd JC
N Engl J Med; 2018 Dec; 379(26):2517-2528. PubMed ID: 30501481
[TBL] [Abstract][Full Text] [Related]
12. A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL.
Jain N; Balakrishnan K; Ferrajoli A; O'Brien SM; Burger JA; Kadia TM; Cortes JE; Ayres ML; Tambaro FP; Keating MJ; Gandhi V; Wierda WG
Oncotarget; 2017 Mar; 8(13):22104-22112. PubMed ID: 27655665
[TBL] [Abstract][Full Text] [Related]
13. Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Tam CS; Brown JR; Kahl BS; Ghia P; Giannopoulos K; Jurczak W; Šimkovič M; Shadman M; Österborg A; Laurenti L; Walker P; Opat S; Chan H; Ciepluch H; Greil R; Tani M; Trněný M; Brander DM; Flinn IW; Grosicki S; Verner E; Tedeschi A; Li J; Tian T; Zhou L; Marimpietri C; Paik JC; Cohen A; Huang J; Robak T; Hillmen P
Lancet Oncol; 2022 Aug; 23(8):1031-1043. PubMed ID: 35810754
[TBL] [Abstract][Full Text] [Related]
14. Combo Therapy Effective for Relapsed CLL.
Cancer Discov; 2015 Jul; 5(7):OF8. PubMed ID: 26034053
[No Abstract] [Full Text] [Related]
15. First reported association of chronic lymphocytic leukaemia and interstitial granulomatous dermatitis.
Riaz IB; Kamal MU; Segal RJ; Anwer F
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27194675
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus-associated haemophagocytic lymphohistiocytosis: a rare cause of febrile neutropenia during cancer chemotherapy.
Bergmann K; Møller HEH; Bergmann OJ
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30217800
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience.
Moore L; Bartels T; Persky DO; Abraham I; Kumar A; McBride A
Support Care Cancer; 2021 Aug; 29(8):4867-4874. PubMed ID: 33547525
[TBL] [Abstract][Full Text] [Related]
18. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report.
Boddu P; Schlette E; Thakral B; Tang G; Pemmaraju N; Kadia T; Ferrajoli A; Ravandi F; Wierda W; Jain N
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):161-165. PubMed ID: 28830803
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of NKCD56bright cells in monitoring the progression of chronic lymphocytic leukemia during treatment.
Blachnio K; Grygalewicz B; Woroniecka R; Rygier J; Pienkowska-Grela B; Rymkiewicz G; Kawiak J
Folia Histochem Cytobiol; 2022; 60(3):203-214. PubMed ID: 36045602
[TBL] [Abstract][Full Text] [Related]
20. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases.
Eren R; Suyanı E
Turk J Haematol; 2018 Nov; 35(4):312-313. PubMed ID: 29983407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
